DarioHealth Corp., a prominent entity in the global digital health sector, has announced a significant strategic commercial agreement with GreenKey Health, an innovator specializing in value-based sleep health solutions. This collaboration is designed to offer a comprehensive care program to payers across the nation, specifically targeting the substantial $150 billion sleep apnea market in the United States. This market impacts over 29 million Americans, with a striking statistic indicating that up to 80% of moderate to severe cases of Obstructive Sleep Apnea (OSA) remain undiagnosed, contributing to over $150 billion in annual U.S. costs due to associated cardiometabolic and behavioral comorbidities such as diabetes, obesity, hypertension, and depression.

The alliance between Dario and GreenKey unites Dario's clinically validated, artificial intelligence (AI)-powered solutions for cardiometabolic and behavioral health with GreenKey's distinctive 'sleep-first' approach to OSA management. Together, they aim to raise awareness and secure crucial payer contracts through a robust multi-channel marketing strategy. This plan is set to engage a wide array of stakeholders, including Commercial, ASO (Administrative Services Only), Medicaid, and Medicare Advantage plans, as well as self-funded employers, consultants, brokers, and various value-based care providers. The immediate launch phase of this collaboration will prioritize engaging large payers as strategic channel collaborators while simultaneously establishing a national network of aligned service providers.

This strategic initiative is particularly timely as payers increasingly shift towards value-based care models, creating a pressing demand for integrated solutions that can effectively address interconnected chronic conditions. The combined strengths of GreenKey's sleep-first approach and Dario's established cardiometabolic and behavioral health programs deliver a holistic, data-driven solution. This solution is engineered to enhance clinical outcomes, reduce overall healthcare costs, and meet the market's need for comprehensive, high-return-on-investment (ROI) chronic condition management.

Steven Nelson, Chief Commercial Officer at Dario, emphasized the transformative potential of this agreement, stating, "We believe that this agreement marks a pivotal step forward in reshaping how chronic conditions like sleep apnea and cardiometabolic disorders are addressed in tandem. By combining our real-time engagement and data-driven platform with GreenKey's powerful OSA cost-saving engine, we are offering payers a differentiated, value-based care solution that not only improves health outcomes but significantly reduces the total cost of care." He further noted that this collaboration opens access to a multi-billion-dollar market, aligning perfectly with Dario's mission to provide integrated, data-driven solutions for the most prevalent and costly chronic conditions in healthcare today.

The joint solution is structured as a comprehensive, tiered program designed to deliver multiple benefits. These include improved member outcomes through enhanced sleep health, optimized GLP-1 utilization, and effective comorbidity management. Furthermore, it aims for reduced healthcare costs by decreasing Emergency Department and inpatient utilization, alongside increased productivity stemming from better sleep and overall health. The program also promises actionable data insights to continuously optimize its performance, leveraging studies that show even a 10% weight loss can substantially reduce the apnea–hypopnea index (AHI), a key measure of sleep apnea severity.

Michael Markus, Chief Executive Officer of GreenKey Health, expressed enthusiasm for the collaboration, stating, "Our collaboration offers payers a unique opportunity to activate a clinically integrated funnel that identifies the right patients for the right programs—starting with sleep and extending through behavior and cardiometabolic health. This is how we redefine chronic care for the modern healthcare system." By integrating behavioral health and a sleep-first approach with precision cardiometabolic interventions, the Dario-GreenKey partnership provides a superior offering that addresses the growing demand for measurable, integrated chronic care solutions.

DarioHealth Corp. is recognized for revolutionizing chronic condition management through its user-centric, multi-chronic condition digital therapeutics platform, which provides personalized interventions for conditions like diabetes, hypertension, and behavioral health. GreenKey Health is a pioneering company dedicated to addressing obstructive sleep apnea through value-based care, with its GreenKey4Life platform empowering payers to improve outcomes and reduce costs via an integrated, sleep-first approach.